Yuan-Xiang Shi
Overview
Explore the profile of Yuan-Xiang Shi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
198
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shi Y, Wang J, Jiang Z, Yan J
J Cancer
. 2025 Feb;
16(4):1363-1378.
PMID: 39895786
Ubiquitination is involved in several tumor immunomodulatory processes, and targeting E3 ubiquitin ligases has substantial potential in cancer therapy. In this study, the key E3 ubiquitin ligases involved in regulating...
2.
Shi Y, Dai P, Chen T, Yan J
Heliyon
. 2024 Jul;
10(12):e33206.
PMID: 39021988
Background: Egl-9 family hypoxia-inducible factor 3 (EGLN3) is involved in the regulation of tumor microenvironment and tumor progression. However, its biological function and clinical significance in various cancers remain unclear....
3.
Shi Y, Yan J, Liu W, Deng J
BMC Cancer
. 2023 May;
23(1):408.
PMID: 37149576
Background: More and more studies have demonstrated that potassium channel tetramerization domain-containing 5 (KCTD5) plays an important role in the development of cancer, but there is a lack of comprehensive...
4.
Shi Y, Dai P, Jiang Y, Wang Y, Liu W
Transl Oncol
. 2023 Mar;
31:101658.
PMID: 36944275
Background: During mitosis and meiosis, centromere proteins (CENPs) play a key role in proper chromosome segregation. Abnormal expression of CENPs leads to chromosome instability, which is the main cause of...
5.
Shi Y, Zhang W, Dai P, Deng J, Tan L
Sci Rep
. 2022 Jun;
12(1):9938.
PMID: 35705627
To obtain novel insights into the tumor biology and therapeutic targets of LUAD, we performed a comprehensive analysis of the KCTD family genes. The expression patterns and clinical significance of...
6.
Shi Y
Oncol Lett
. 2021 Aug;
22(3):685.
PMID: 34434284
Lung cancer is a major public health problem worldwide, with a high associated incidence and mortality. In the present study, novel epigenetic signatures were identified through genome-wide DNA methylation microarrays....
7.
Shi Y, Sheng D, Cheng L, Song X
J Oncol
. 2020 Jan;
2019:8107318.
PMID: 31889956
Lung cancer is the leading cause of cancer-related mortality worldwide. Tumorigenesis involves a multistep process resulting from the interactions of genetic, epigenetic, and environmental factors. Genome-wide association studies and sequencing...
8.
Shi Y, Wang Y, Li X, Zhang W, Zhou H, Yin J, et al.
BMC Genomics
. 2017 Nov;
18(1):901.
PMID: 29169318
Background: Epigenetic alterations are strongly associated with the development of cancer. The aim of this study was to identify epigenetic pattern in squamous cell lung cancer (LUSC) on a genome-wide...
9.
Shi Y, Yin J, Shen Y, Zhang W, Zhou H, Liu Z
Sci Rep
. 2017 Aug;
7(1):8072.
PMID: 28808310
This study aims to identify promising biomarkers for the early detection of lung cancer and evaluate the prognosis of lung cancer patients. Genome-wide mRNA expression data obtained from the Gene...
10.
Shi Y, Zhu T, Zou T, Zhuo W, Chen Y, Huang M, et al.
Oncotarget
. 2016 Nov;
7(51):85235-85243.
PMID: 27835911
Lung cancer remains as the leading cause of cancer-related death worldwide, and lung adenocarcinoma (LUAD) is the most common histological subtype. This study aims to investigate biomarkers associated with cancer...